Researchers at Princeton University are developing new “gene promoters” – which act like switches to turn genes on – for use with gene therapy, the delivery of new genes to replace ones that are faulty. The new promoters work especially well for brain and other neurological disorders and provide longer-lasting functionality compared to other promoters.
- Predictive value of blood pressure, heart rate, and blood pressure/heart rate ratio in a Chinese subpopulation with vasovagal syncope
- Risk factors for intraoperative pressure injury in aortic surgery
- ECMO/CRRT in the treatment of critically ill SARS-CoV-2 pneumonia patients
- Regulating the ribosomal RNA production line
- New technique builds super-hard metals from nanoparticles